SEC to meet again to decide on full market nod for Covaxin, Covishield

"The data is huge which has to be reviewed and it needs a considerable amount of time. The SEC will…

U.S. FDA approves drugs from AbbVie, Pfizer to treat eczema

AbbVie’s Rinvoq and Pfizer’s Cibinqo have been approved to treat moderate-to-severe atopic dermatitis, or eczema, in patients who do not…

J&J reaches opioid settlement with holdout U.S. state New Mexico

The New Brunswick, New Jersey-based drugmaker said the $44 million was consistent with the terms of a proposal for J&J…

Urgent Opening For Production (Inje.) Dept. @ Rusan Pharma Ltd

Urgent Opening For Production (Inje.) Dept. @ Rusan Pharma Ltd There is an opening for Asst. Mgr. to Manager for…

Operations work from home job/internship at Medisolve Pharma Pvt Ltd

Operations work from home job/internship at Medisolve Pharma Pvt Ltd About Medisolve Pharma Pvt Ltd Medisolve is the Leading online…

Business Analyst- Pharma Execution

Business Analyst- Pharma Execution Job Description : Business Analyst- Pharma Execution Hyderabad, Andhra Pradesh Scope * The BA will provide…,…

43% pharma marketers prefer programmatic messaging platforms in India

Telehealth platforms leveraging programmatic solutions to better engage healthcare experts, creating a huge opportunity for pharma brands Original source: https://health.economictimes.indiatimes.com/news/pharma/88893856?utm_source=RSS&utm_medium=ETRSS

WHO recommends Baricitinib use to treat severe Covid

The latest recommendation for Baricitinib has been made on “moderate certainty evidence,” based on three randomised controlled Baricitinib trials conducted…

DGCI to review applications for full market approval of Covaxin, Covishield today

The move comes after the Hyderabad-based Bharat Biotech on Thursday announced that its indigenously developed Covid-19 vaccine Coavaxin is now…

FDA Roundup: January 14, 2022

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Original source: http://www.fda.gov/news-events/press-announcements/fda-roundup-january-14-2022